4
Changes in Ownership
ACADIA PHARMACEUTICALS INC Filed Acc 0001209191-22-002750
EVP & General Counsel sold 574 shares at $23.05 ($13,231)
- EVP & General Counsel acquired 1,633 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| KIM AUSTIN D. EVP & General Counsel | 2022-01-06 | Option exercise | +1,633 | 13,774 | D | ||
| KIM AUSTIN D. EVP & General Counsel | 2022-01-06 | Sale | −574 | $23.05 | $13,231 | 13,200 | D |
| Derivatives | |||||||
| KIM AUSTIN D. EVP & General Counsel | 2022-01-06 | Option exercise · Restricted Stock Units | −1,633 | 3,267 | D | ||
| Open-market sales · 574 sh · avg $23.05 · $13,231 | |||||||
Loading xslF345X03/doc4.xml…